35 Stocks Moving In Monday's Mid-Day Session

Gainers

• American Electric Technologies, Inc AETI shares jumped 135.2 percent to $1.74 after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
• BIO-key International, Inc. BKYI surged 34.5 percent to $3.00. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
• Deciphera Pharmaceuticals, Inc. DCPH shares rose 24.6 percent to $32.285 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
• Highpower International Inc HPJ shares gained 15.9 percent to $3.332.
• CSS Industries, Inc. CSS climbed 11.5 percent to $18.035. DA Davidson upgraded CSS Industries from Neutral to Buy.
• Denali Therapeutics Inc. DNLI rose 10.8 percent to $20.88.
• Immunomedics, Inc. IMMU shares climbed 10.2 percent to $25.02. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
• China Natural Resources, Inc. CHNR rose 10.1 percent to $2.69.
• Genomic Health, Inc. GHDX shares climbed 10 percent to $43.6652 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
• Evolus, Inc. EOLS climbed 7.4 percent to $29.31.
• Petróleo Brasileiro S.A. - Petrobras PBRA shares gained 7.1 percent to $9.165.
• PFSweb, Inc. PFSW gained 7.1 percent to $11.6776.
• Digital Ally, Inc. DGLY rose 4 percent to $2.75 after the company reported that the US Patent Office has denied Axon's request to invalidate a Digital Ally patent.

Check out these big penny stock gainers and losers

Losers

• Nektar Therapeutics NKTR shares dipped 41.3 percent to $52.9990. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
• Jounce Therapeutics, Inc. JNCE fell 37.4 percent to $7.015 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
• Daqo New Energy Corp. DQ shares fell 21.2 percent to $41.56 after dropping 8.57 percent on Friday.
• Vaxart, Inc. VXRT dropped 17.9 percent to $4.304 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
• Gevo, Inc. GEVO dipped 16.1 percent to $4.03.
• Blueprint Medicines Corporation BPMC shares fell 14.8 percent to $72.00. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
• Amtech Systems, Inc. ASYS tumbled 14.8 percent to $8.45.
• JinkoSolar Holding Co., Ltd. JKS fell 14.1 percent to $13.00 after dropping 14.07 percent on Friday.
• PPDAI Group Inc. PPDF fell 13.4 percent to $6.66.
• Zymeworks Inc. ZYME dropped 13 percent to $19.0132.
• G1 Therapeutics, Inc. GTHX shares dipped 13 percent to $37.95 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
• Co-Diagnostics, Inc. CODX fell 12.3 percent to $4.20 after climbing 65.17 percent on Friday.
• Moxian, Inc. MOXC shares declined 10.8 percent to $1.91.
• NovoCure Limited NVCR dropped 10.3 percent to $28.675. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
• ChemoCentryx, Inc. CCXI fell 9.5 percent to $11.73.
• Viking Therapeutics, Inc. VKTX dropped 8.5 percent to $8.9191 after falling 2.40 percent on Friday. Viking Therapeutics shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals, which announced data from a Phase 2 study of its non-alcoholic steatohepatitis pipeline candidate.
• CRISPR Therapeutics AG CRSP fell 7.9 percent to $61.850 after declining 2.58 percent on Friday.
• Enphase Energy, Inc. ENPH dropped 7.4 percent to $5.35. Enphase Energy named Eric Branderiz as Vice President and Chief Financial Officer.
• Tactile Systems Technology, Inc. TCMD slipped 6.6 percent to $47.10. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
• Colfax Corporation CFX fell 6.1 percent to $28.89. Bank of America downgraded Colfax from Buy to Underperform.
• The Trade Desk, Inc. TTD dropped 5.9 percent to $81.505. Wells Fargo downgraded Trade Desk from Outperform to Market Perform.
• Viper Energy Partners LP VNOM fell 5.3 percent to $28.80. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.